The past 1–2 years have seen major developments in the area of CMV management in
transplant recipients. Expanding diagnostic and therapeutic capabilities provide a …

We recommend that clinicians tailor their approach to the individual based on their
underlying immune deficit and maintain a high index of suspicion and low threshold for …

Background: Cytomegalovirus (CMV)-specific cell-mediated immunity is important for control
of CMV after transplant. Assays exist to measure this, but their place in therapy is unclear …

Objectives Bloodstream infections (BSI) are prevalent after solid organ transplantation
(SOT). In this study, we aimed to investigate the incidence and risk factors for BSI in the first …

Background Common Variable Immunodeficiency (CVID) is classified as a 'Predominantly
Antibody Deficiency'(PAD), but there is emerging evidence of cellular immunodeficiency in a …

Human cytomegalovirus (CMV) infection, which is one of the most common complications in
transplant recipients, increases the risk of graft loss and rejection. Laboratory strategies for …

Introduction Herpes virus infections are a major concern after solid organ transplantation
and linked to the immune function of the recipient. We aimed to determine the incidence of …

Reliable methods to assess immune function after solid organ transplantation (SOT) are
needed to guide dosing of immunosuppression. We hypothesized that toll‐like receptor …

Objective This study aimed to compare the accuracy of QuantiFERON‐TB Gold Plus (QFT‐
Plus) and T‐SPOT. TB for diagnosing active tuberculosis (ATB) in febrile patients, to explore …

Delayed graft function (DGF) is a type of acute renal failure that is closely linked to the
immune system. The objective of this study is to investigate immune trends during the …